Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Gut ; 57(3): 352-64, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17989109

ABSTRACT

BACKGROUND: Endogenous opioids modulate the growth of nervous and non-nervous cells. Hepatic stellate cells (HSCs) are the main cell phenotype involved in liver fibrogenesis, display molecular markers of neuronal cells and respond to neurotransmitters. AIM: To evaluate the role of endogenous opioids on liver fibrogenesis. METHODS: Activated rat HSCs (passage 1-3) were used to evaluate cell proliferation and intracellular signalling pathway activation. Liver fibrosis was induced in rats by dimethylnitrosamine (DMN) administration. RESULTS: Opioid receptors showed a different pattern of expression when measured in quiescent and activated (in vitro and in vivo) HSCs. The activation of opioid receptors increased HSC proliferation and collagen accumulation. Opioid receptor stimulation induced a calcium-dependent protein kinase C alpha (PKC alpha)/extracellular regulated kinase (ERK)/phosphatidylinositol 3-kinase (PI3K) pathway activation that mediated the effect of endogenous opioids on HSC proliferation and collagen synthesis. In DMN-treated rats, the opioid antagonist naloxone reduced alpha-smooth muscle actin expression (as a marker of HSC activation) and collagen deposition, both measured by morphometry after 5 weeks of treatment. In both DMN-treated rats and human liver biopsies from chronic liver diseases, opioid receptors were observed in HSCs in area of active fibrogenesis. The endogenous opioid met-enkephalin increased its expression in zone 3 hepatocytes close to the area of necrosis after DMN administration and in the cellular target of chronic liver injury in human biopsies, and stimulated HSC proliferation and collagen synthesis. CONCLUSIONS: Endogenous opioids released during chronic liver injury participate in the process of liver fibrogenesis by stimulating HSC proliferation and collagen production in a paracrine manner.


Subject(s)
Hepatocytes/physiology , Liver Cirrhosis, Experimental/pathology , Opioid Peptides/physiology , Animals , Cell Proliferation , Cells, Cultured , Chronic Disease , Collagen Type I/metabolism , Dimethylnitrosamine , Disease Progression , Enkephalin, Methionine/metabolism , Enkephalin, Methionine/pharmacology , Hepatocytes/drug effects , Hepatocytes/metabolism , Humans , Liver/metabolism , Liver Cirrhosis, Experimental/chemically induced , Liver Cirrhosis, Experimental/metabolism , Liver Diseases/metabolism , Male , Paracrine Communication , Rats , Receptors, Opioid/metabolism , Signal Transduction/physiology
2.
Toxicon ; 48(2): 160-74, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16828137

ABSTRACT

The cyanobacterium Planktothrix rubescens Anagnostidis & Komarek (previously Oscillatoria rubescens DC ex Gomont) is present in several Italian lakes and it is known to produce cyanotoxins. The dynamics and toxin production of P. rubescens population in Lake Albano, a volcanic crater lake in Central Italy, has been studied for 5 years (January 2001-April 2005). Winter-spring superficial blooms with frequent scums were observed every year. Total microcystin (MC) levels were measured from April 2004 to October 2005 by liquid chromatography-tandem mass spectrometry. MC levels up to 14.2mug/l were measured, with high concentrations found in summer at a 20-25m depth. The intracellular toxin content varied between 1.5 (surface, January 2004) and 0.21pg/cell (surface, May 2004). Six different MCs were detected, the most abundant being two desmethyl-MC-RR isomers. Of the 13 water wells monitored in the Lake Albano area, two of them showed MC contamination during winter, confirming the ability of these toxins to migrate through groundwater towards public water sources. These results highlight the need for further studies on the mobility and fate of these pervasive cyanobacterial toxins.


Subject(s)
Bacterial Toxins/biosynthesis , Cyanobacteria/metabolism , Environmental Monitoring , Fresh Water/microbiology , Peptides, Cyclic/biosynthesis , Water Microbiology , Chromatography, High Pressure Liquid , Cyanobacteria/growth & development , Fresh Water/chemistry , Italy , Mass Spectrometry , Microcystins , Seasons , Water Pollutants/analysis
3.
Gut ; 53(11): 1688-97, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15479693

ABSTRACT

BACKGROUND/AIMS: Thiazolidinediones (TZD) are a new class of oral antidiabetic drugs that have been shown to inhibit growth of some epithelial cancer cells. Although TZD were found to be ligands for peroxisome proliferators activated receptor gamma (PPARgamma) the mechanism by which TZD exert their anticancer effect is currently unclear. Furthermore, the effect of TZD on local motility and metastatic potential of cancer cells is unknown. The authors analysed the effects of two TZD, rosiglitazone and pioglitazone, on invasiveness of human pancreatic carcinoma cell lines in order to evaluate the potential therapeutic use of these drugs in pancreatic adenocarcinoma. METHODS: Expression of PPARgamma in human pancreatic adenocarcinomas and pancreatic carcinoma cell lines was measured by reverse transcription polymerase chain reaction and confirmed by western blot analysis. PPARgamma activity was evaluated by transient reporter gene assay. Invasion assay was performed in modified Boyden chambers. Gelatinolytic and fibrinolytic activity were evaluated by gel zymography. RESULTS: TZD inhibited pancreatic cancer cells' invasiveness, affecting gelatinolytic and fibrinolytic activity with a mechanism independent of PPARgamma activation and involving MMP-2 and PAI-1 expression. CONCLUSION: TZD treatment in pancreatic cancer cells has potent inhibitory effects on growth and invasiveness suggesting that these drugs may have application for prevention and treatment of pancreatic cancer in humans.


Subject(s)
Adenocarcinoma/pathology , Antineoplastic Agents/pharmacology , Pancreatic Neoplasms/pathology , Thiazolidinediones/pharmacology , Adenocarcinoma/metabolism , Adult , Aged , Cell Division/drug effects , DNA, Neoplasm/biosynthesis , Dose-Response Relationship, Drug , Female , Gene Expression Regulation/drug effects , Humans , Male , Matrix Metalloproteinases/genetics , Matrix Metalloproteinases/metabolism , Middle Aged , Neoplasm Invasiveness/prevention & control , PPAR gamma/genetics , PPAR gamma/metabolism , PPAR gamma/physiology , Pancreatic Neoplasms/metabolism , Pioglitazone , Plasminogen Activators/genetics , Plasminogen Activators/metabolism , RNA, Messenger/genetics , RNA, Neoplasm/genetics , Rosiglitazone , Tumor Cells, Cultured
4.
Growth Factors ; 19(2): 87-100, 2001.
Article in English | MEDLINE | ID: mdl-11769974

ABSTRACT

The activation of hepatic stellate cells (HSC) during liver fibrogenesis has been shown to be mediated by paracrine and autocrine loops involving transforming growth factor-beta1 (TGF-beta1) as the main fibrogenic mediator secreted by activated macrophages, endothelial cells and liberated by disintegrated platelets. The cell-associated plasminogen activation system regulates extracellular matrix (ECM) catabolism and cell movement. We have studied whether TGF-beta1 could modulate the plasminogen activation system in human HSC and the role of such protease system in the activity of TGF-beta1 on HSC. Urokinase plasminogen activator receptors (u-PAR), u-PA and plasminogen activator inhibitor type 1 (PAI-1) were determined by immunoassay and RNase protection assay. Cell migration, evaluated either as chemotaxis or as chemoinvasion, was studied in Boyden chambers after addition of TGF-beta1, and inhibition with anti-u-PA and anti-u-PAR antagonists [antibodies against u-PA and u-PAR and antisense oligonucleotides (aODN) against u-PAR mRNA]. We have shown that TGF-beta1 is not mitogenic for HSC, while it is a powerful motogen either in chemotaxis or chemoinvasion assays. TGF-beta1 up-regulates the synthesis and expression of PAI-1, as well as u-PAR expression and exposure at the cell membrane, while it does not affect u-PA levels. TGF-beta1-dependent chemoinvasion of reconstituted basement membrane exploits the cell-associated plasminogen activation system, since it is blocked by monoclonal antibodies against u-PA and against various u-PAR domains, as well as by anti-u-PAR aODN. We have also observed a cumulative effect of TGF-beta1, b-FGF and PDGF in the invasion assay of HSC: in the presence of low amounts of TGF-beta1 the chemoinvasive activity of PDGF and bFGF is dramatically increased. Also this cooperation requires u-PAR and is inhibited by monoclonal antibodies against u-PAR domains I, II and III.


Subject(s)
Fibrinolysis , Liver/cytology , Receptors, Cell Surface/metabolism , Transforming Growth Factor beta/metabolism , Animals , Cell Division , Cell Movement , Cells, Cultured , Collagen/pharmacology , Dose-Response Relationship, Drug , Drug Combinations , Enzyme-Linked Immunosorbent Assay , Fibroblast Growth Factor 2/biosynthesis , Humans , Laminin/pharmacology , Macrophages/metabolism , Mice , Neoplasm Invasiveness , Oligonucleotides, Antisense/pharmacology , Platelet-Derived Growth Factor/biosynthesis , Protein Structure, Tertiary , Proteoglycans/pharmacology , Receptors, Urokinase Plasminogen Activator , Ribonucleases/metabolism , Time Factors , Transforming Growth Factor beta1 , Wound Healing
5.
Hepatology ; 31(1): 101-8, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10613734

ABSTRACT

During liver injury, hepatic stellate cells (HSC) acquire a myofibroblast-like phenotype associated with reduction of lipid droplets, increased collagen synthesis, and proliferation. Peroxisome proliferator-activated receptor gamma (PPARgamma) regulates adipocyte differentiation and controls gene transcription in response to various activators including prostanoids and antidiabetic thiazolidinediones. We explored whether the presence of PPARgamma and its transcriptional activity were involved in control of HSC proliferation in vitro. PPARgamma ligands, 15-deoxy-triangle up(1214) prostaglandin J(2) (15d-PGJ(2)) and ciglitizone, significantly decrease platelet-derived growth factor (PDGF)-induced proliferation in activated human HSC and inhibit alpha smooth muscle actin (alpha-SMA) expression during HSC transdifferentiation. Treatment with 9-cis retinoic acid (9-cisRA) and LG268, ligands of the heterodimerization partner retinoic X receptor (RXR), had a negligible effect in PDGF-treated cells but caused a further reduction of proliferation when used in combination with ciglitizone. Transfection experiments with a reporter gene consisting of 3 copies of a PPAR response element (peroxisome proliferator response element [PPRE](3)-tk-luciferase) showed a progressive reduction of PPAR transcriptional activity during plastic-induced HSC transdifferentiation. Cotransfection with human PPARgamma expression vector restored the PPRE(3)-tk-luciferase reporter expression and the increased level of the receptor in activated HSC-inhibited cell proliferation in a dose-dependent manner. Incubation of human PPARgamma-cotransfected HSC with PDGF strongly inhibited luciferase activity and this effect was blocked by the inhibition of the mitogen-activated protein (MAP) kinase signal cascade. Our results indicate that depression of PPARgamma expression and activity is involved in HSC proliferation and that the PPARgamma ligand-mediated activation exerts a previously unrecognized inhibition of PDGF-induced mitogenesis in activated human HSC.


Subject(s)
Cell Division , Liver/cytology , Platelet-Derived Growth Factor/pharmacology , Receptors, Cytoplasmic and Nuclear/physiology , Thiazolidinediones , Transcription Factors/physiology , Transcription, Genetic , Cell Differentiation , Cells, Cultured , Gene Expression , Gene Expression Regulation , Humans , Prostaglandin D2/analogs & derivatives , Prostaglandin D2/pharmacology , RNA, Messenger/metabolism , Receptors, Cytoplasmic and Nuclear/genetics , Thiazoles/pharmacology , Transcription Factors/genetics , Transfection
6.
Blood ; 94(7): 2200-7, 1999 Oct 01.
Article in English | MEDLINE | ID: mdl-10498589

ABSTRACT

The BCR/ABL hybrid gene plays a central role in the pathogenesis of the chronic phase of chronic myeloid leukemia (CML). We used a very sensitive quantitative reverse transcriptase-polymerase chain reaction to investigate the levels of hybrid BCR/ABL mRNA in bone marrow cells of 20 patients with Philadelphia positive (Ph(+)) CML treated with interferon-alpha (IFN-alpha) as a single agent. Bone marrow samples were collected at diagnosis and at hematologic remission induced by IFN-alpha, or by hydroxyurea in case of resistance to IFN-alpha. The mean levels of BCR/ABL transcripts in bone marrow mononuclear cells of patients who showed a complete hematologic response to IFN-alpha were significantly reduced with respect to those at diagnosis (48 x 10(3) v 168 x 10(3); P <.001), whereas no difference was detected between the values at diagnosis and at hematologic remission in patients resistant to IFN-alpha. In cell culture experiments, IFN-alpha priming significantly reduced the levels of BCR/ABL hybrid transcripts in a dose-dependent manner in Ph+ bone marrow precursors obtained at diagnosis from patients who subsequently responded to IFN-alpha treatment (P < .005). No downmodulation was observed in bone marrow precursors from patients who subsequently proved to be IFN-resistant. These results indicate that downmodulation of BCR/ABL gene expression could be one of the mechanisms involved in the response of CML patients to IFN-alpha treatment.


Subject(s)
Fusion Proteins, bcr-abl/genetics , Gene Expression Regulation, Neoplastic/drug effects , Interferon-alpha/therapeutic use , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics , Transcription, Genetic , Antineoplastic Agents/therapeutic use , Bone Marrow Cells/metabolism , Bone Marrow Cells/pathology , Cells, Cultured , Dose-Response Relationship, Drug , Gene Expression Regulation, Neoplastic/immunology , Humans , Hydroxyurea/therapeutic use , Leukocyte Count , Monocytes/metabolism , Monocytes/pathology , Philadelphia Chromosome , Platelet Count , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction
7.
J Hepatol ; 30(5): 868-75, 1999 May.
Article in English | MEDLINE | ID: mdl-10365814

ABSTRACT

BACKGROUND/AIMS: Oxidative stress is associated with liver fibrosis in vivo and with hepatic stellate cell (HSC) activation in vitro, but the intracellular mechanisms mediating these effects are mostly unknown. The Na+/H+ exchanger plays a key role in regulating the cell cycle, and is involved in HSC proliferation. Its role in different HSC features, such as collagen accumulation, is still unknown. We thus evaluated if the Na+/H+ exchanger modulates the fibrogenic effect of oxidative stress in rat HSC. METHODS: HSC were incubated with 0.1 mM ferric nitrilotriacetate complex (FeNTA). Intracellular hydroperoxides and malonildialdehyde (MDA) levels in the culture media were measured by the dichlorofluorescein and TBARS method, respectively. Intracellular pH and Na+/H+ exchanger activity were measured using the fluorescent dye BCECF. Cell proliferation was measured by immunohistochemistry for bromodeoxyuridine incorporation. Collagen type I accumulation in the culture media was measured by ELISA. RESULTS: HSC incubation with FeNTA resulted in a significant production of intracellular hydroperoxides and MDA, associated with increased Na+/H+ exchange activity and baseline intracellular pH (pHi). Exposure of HSC to FeNTA significantly enhanced the number of proliferating HSC and collagen type I levels in the culture medium. All these effects were reversed by the antioxidant resveratrol and by the Na+/H+ exchanger inhibitor amiloride. CONCLUSIONS: This study indicates that the Na+/H+ exchanger might represent a common mediator of the different effects induced by oxidative stress on HSC. The reduction in cell proliferation and collagen synthesis induced by amiloride could represent a new therapeutic challenge in liver fibrosis.


Subject(s)
Liver/physiology , Oxidative Stress/physiology , Sodium-Hydrogen Exchangers/metabolism , Animals , Antioxidants/pharmacology , Carcinogens/pharmacology , Cell Cycle , Cell Division , Cells, Cultured , Collagen/metabolism , Culture Media , Ferric Compounds/pharmacology , Fluoresceins , Fluorescent Dyes , Kinetics , Liver/cytology , Liver/pathology , Liver Cirrhosis, Experimental/pathology , Liver Cirrhosis, Experimental/physiopathology , Liver Cirrhosis, Experimental/prevention & control , Malondialdehyde/metabolism , Nitrilotriacetic Acid/analogs & derivatives , Nitrilotriacetic Acid/pharmacology , Oxidative Stress/drug effects , Rats , Resveratrol , Stilbenes/pharmacology , Thiobarbituric Acid Reactive Substances/analysis
8.
Hepatology ; 29(3): 868-78, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10051491

ABSTRACT

During liver fibrogenesis, hepatic stellate cells (HSC) proliferate and migrate under the influence of growth factors, including platelet-derived growth factor (PDGF) and basic-fibroblast growth factor (b-FGF). The plasminogen activation system regulates extracellular matrix (ECM) catabolism and cell movement. We evaluated the expression and biological functions of the plasminogen activation system in human HSC and its interaction with PDGF and b-FGF. Urokinase-plasminogen activator receptors (u-PAR) were measured by radioligand binding, cell cross-linking, immunoassay, and RNAse protection assay. u-PA and plasminogen activator inhibitors (PAIs) expression and activities were analyzed by zymography, immunoassay, and RNase protection assay. Cell migration and proliferation, studied in Boyden chambers and by microscopic counting, were evaluated after the addition of PDGF, b-FGF, and blockade with anti-u-PA, anti-u-PAR antibodies, and antisense oligodeoxynucleotides (aODN) against u-PAR mRNA. We have shown that HSC produce u-PAR, u-PA, and PAI-1. PDGF and b-FGF up-regulate u-PA and u-PAR, but not PAI-1, and exogenous addition of u-PA stimulates HSC proliferation, chemotaxis, and chemoinvasion. Inhibition of u-PA/u-PAR with antibodies against u-PA or u-PAR and with u-PAR aODN inhibit the proliferative, chemotactic, and chemoinvasive activity of PDGF and b-FGF. These findings indicate that u-PA and u-PAR are required for the mitogenic and chemoinvasive activity of PDGF and b-FGF on HSC.


Subject(s)
Fibrinolysis/physiology , Fibroblast Growth Factor 2/physiology , Liver/physiology , Platelet-Derived Growth Factor/physiology , Cell Division/drug effects , Cell Movement/drug effects , Dose-Response Relationship, Drug , Extracellular Matrix/physiology , Fibrinolysis/drug effects , Growth Substances/pharmacology , Humans , Liver/cytology , Liver/drug effects , Oligonucleotides, Antisense/pharmacology , Plasminogen Activators/pharmacology , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Receptors, Urokinase Plasminogen Activator , Urokinase-Type Plasminogen Activator/metabolism , Urokinase-Type Plasminogen Activator/pharmacology
9.
Am J Cardiol ; 83(5): 775-6, A9, 1999 Mar 01.
Article in English | MEDLINE | ID: mdl-10080436

ABSTRACT

This study compared the incidence of postoperative atrial fibrillation in a group of 34 patients undergoing coronary artery bypass graft surgery without the use of cardiopulmonary bypass and cardioplegia with a control group of 747 patients undergoing coronary artery bypass graft surgery using cardiopulmonary bypass and standard cardioplegia. A trend toward a lower incidence of postoperative atrial fibrillation was found in the group that underwent coronary artery bypass graft surgery without the use of cardiopulmonary bypass (n = 0.06).


Subject(s)
Atrial Fibrillation/etiology , Cardiopulmonary Bypass/adverse effects , Coronary Artery Bypass/adverse effects , Adrenergic beta-Antagonists/administration & dosage , Adrenergic beta-Antagonists/therapeutic use , Aged , Analysis of Variance , Chi-Square Distribution , Cohort Studies , Coronary Artery Bypass/methods , Electrocardiography, Ambulatory , Female , Heart Arrest, Induced/adverse effects , Heart Rate/drug effects , Humans , Incidence , Intraoperative Care , Male , Minimally Invasive Surgical Procedures , Propanolamines/administration & dosage , Propanolamines/therapeutic use , Retrospective Studies , Stroke Volume/physiology
10.
J Hepatol ; 28(1): 40-5, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9537862

ABSTRACT

BACKGROUND/AIMS: Alcohol dehydrogenase, cytochrome P4502E1 (CYP2E1), and aldehyde dehydrogenase are known to play an important role in alcohol metabolism in the liver. Although the ethanol oxidation pathways are mainly localized in hepatocytes, we examine whether human hepatic stellate cells might also metabolize ethanol and acetaldehyde. METHODS: Hepatic stellate cells were isolated from normal human livers and exposed in vitro to 50 mmol/l ethanol or 85 micromol/l acetaldehyde for different periods of time. Alcohol dehydrogenase/aldehyde dehydrogenase activity and CYP2E1 protein expression were measured in hepatic stellate cells. Moreover, alcohol dehydrogenase and aldehyde dehydrogenase mRNA expression were evaluated in hepatic stellate cells. RESULTS: Exposure of hepatic stellate cells to ethanol for 24 h resulted in a 5-fold increase in cell alcohol dehydrogenase activity. The effect of ethanol on alcohol dehydrogenase activity was paralleled by a significant increase in the alcohol dehydrogenase mRNA expression in hepatic stellate cells. Acetaldehyde significantly increased the activity of high affinity aldehyde dehydrogenase in hepatic stellate cells, whereas ethanol was devoid of any effect. Acetaldehyde also induced high affinity aldehyde dehydrogenase mRNA expression in hepatic stellate cells. CYP2E1 was not expressed in hepatic stellate cells either in basal condition or after ethanol/acetaldehyde exposure. CONCLUSIONS: This study shows that human hepatic stellate cells have the capacity to metabolize both ethanol and acetaldehyde through a class I alcohol dehydrogenase- and an aldehyde dehydrogenase-oxidizing pathway. Conversely, no detectable levels of CYP2E1-associated proteins are expressed in these cells.


Subject(s)
Acetaldehyde/pharmacology , Alcohol Dehydrogenase/biosynthesis , Ethanol/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Liver/cytology , Liver/enzymology , Alcohol Dehydrogenase/analysis , Cells, Cultured , Cytochrome P-450 CYP2E1/analysis , Cytochrome P-450 CYP2E1/biosynthesis , Humans , RNA, Messenger/biosynthesis , Transcription, Genetic/drug effects
11.
Hepatology ; 27(3): 720-6, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9500700

ABSTRACT

Oxidative stress is associated with liver fibrosis and with hepatic stellate cell (HSC) activation in vivo. However, it remains controversial whether oxidative stress contributes to HSC activation either directly or through a paracrine stimulation by damaged hepatocytes. A medium containing products released from cells undergoing oxidative stress was obtained after incubation of hepatocytes with (HCM/Fe) or without (HCM) 0.1 mmol/L ferric nitrilotriacetate complex (FeNTA). Exposure of HSC to HCM/Fe for 24 hours significantly increased the number of proliferating HSC compared with HCM and to controls at all dilutions tested. The simultaneous coincubation of HSC with HCM/Fe and desferrioxamine (50 micromol/L) did not reduce the observed increase in cell proliferation, thus excluding a role for eventually contaminating iron in HCM/Fe. HCM/Fe induced also a significant increase in collagen type I accumulation in HSC culture media. To study the cellular mechanism underlying HCM/Fe effects, we evaluated the activity of the Na+/H+ exchanger, which plays a role in regulating HSC proliferation. The incubation of HSC for 24 hours with HCM/Fe significantly increased baseline intracellular pH (pHi) and Na+/H+ exchanger activity, indicating a plausible role of this antiport in mediating cell response. In conclusion, hepatocytes undergoing oxidative stress release factors which are fibrogenic for HSC, thereby, confirming what has been only hypothesized in vivo. In addition, HSC proliferation is associated with changes in the Na+/H+ exchanger activity, thus providing a useful target for the evaluation of inhibitors of this pathway for the treatment of hepatic fibrosis.


Subject(s)
Liver Cirrhosis, Experimental/etiology , Liver/metabolism , Oxidative Stress , Animals , Collagen/metabolism , Culture Media, Conditioned , Hydrogen-Ion Concentration , Lipid Peroxidation , Liver/cytology , Liver Cirrhosis, Experimental/therapy , Male , Rats , Rats, Sprague-Dawley , Sodium-Hydrogen Exchangers/analysis
12.
Hepatology ; 25(2): 361-7, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9021948

ABSTRACT

Experimental evidence indicates that the lipid peroxidation of biological membranes is often associated with the development of liver fibrosis. We have studied the effect of neutrophil-derived reactive oxygen species (ROS) on collagen synthesis by human hepatic stellate cells (HSC), the major source of collagen in the liver, in a coculture system. Lipid peroxidation in the cocultures was evaluated in terms of either malondialdehyde (MDA) production or the formation of MDA/4-hydroxynonenal protein adducts. The expression of cellular messenger RNAs (mRNAs) was evaluated by either Northern blotting or RNAse protection assay. Nitric oxide (NO) synthase activity in cells was measured by [3H]citrulline formation from [3H]arginine. In vitro exposure of HSC to ROS resulted in the early induction of lipid peroxidation and was associated with a marked increase (threefold) of procollagen I mRNA expression and synthesis. The addition of antioxidants, such as vitamin E or superoxide dismutase (SOD), impaired this stimulation. The inhibition of neutrophil NO formation by N(G)-monomethyl-L-arginine made the ROS-induced stimulation of procollagen I more evident. The addition of xanthine/xanthine oxidase X/XO, a superoxide anion donor, to HSC cultures strongly increased procollagen I synthesis. This stimulation was hampered by the addition of both SOD and sodium nitroprusside (an NO donor). The contribution of HSC to the production of NO in our coculture system was negligible, because inducible NO synthase (iNOS) mRNA was almost undetectable in these cells, and also because the amount of NO produced by HSC stimulated with tumor necrosis factor alpha (TNF-alpha) and lipopolysaccharide (LPS) was 500 times less than that synthesized by neutrophils. In conclusion, these results indicate that neutrophil-derived ROS may contribute to the development of hepatic fibrosis associated with alcoholic hepatitis. NO produced by neutrophils may exert a "protective" antioxidant effect by operating as a scavenger of superoxide anion.


Subject(s)
Neutrophils/metabolism , Nitric Oxide/metabolism , Procollagen/metabolism , Reactive Oxygen Species/metabolism , Humans , Nitric Oxide Synthase/metabolism , RNA, Messenger/metabolism , Superoxide Dismutase/metabolism , Vitamin E/pharmacology
13.
Ann Thorac Surg ; 62(5): 1537-8, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8893608

ABSTRACT

Air embolism remains a potential hazard of cardiopulmonary bypass. We describe a simple technique for deairing the heart that is inexpensive and requires no manipulation or extra cannulation of the heart.


Subject(s)
Cardiopulmonary Bypass/adverse effects , Cardiopulmonary Bypass/methods , Embolism, Air/prevention & control , Cardiopulmonary Bypass/instrumentation , Embolism, Air/etiology , Humans , Intraoperative Care , Transducers, Pressure
14.
Alcohol Alcohol ; 29(3): 303-14, 1994 May.
Article in English | MEDLINE | ID: mdl-7945571

ABSTRACT

Hepatic fibrosis is an important morphological feature of alcohol-induced liver injury. We previously reported that acetaldehyde stimulates collagen I and fibronectin gene transcription in rat fat-storing cell (FSC) culture. We here evaluated whether acetaldehyde increases Col I and FN gene transcription through the induction of c-fos and c-jun proto-oncogenes and studied the possible role played by protein kinase C (PKC) and c-AMP. FSCs, isolated from rat liver on a Nycodenz density gradient, were exposed to acetaldehyde for 1/2, 1, 3, 6, 12, 24 hr and for 10, 20, 30, 45, 60, 90 min in the experiments for jun and fos expression, respectively. Acetaldehyde produced a rapid and transient induction of fos mRNA (undetectable at t = 0, peak at t = 45 and still evident at t = 90). Jun mRNA was weakly expressed in unstimulated FSCs; acetaldehyde induced a prolonged activation of jun expression up to 24 hr with a peak at 3 hr. To study the role of PKC were repeated the experiments in the presence of Staurosporine and H-7. These inhibitors of PKC activity blocked the stimulatory effect of acetaldehyde on fos and jun mRNA expression. Furthermore, they abolished the stimulatory effect of acetaldehyde on collagen I and fibronectin gene expression by FSCs. Acetaldehyde increased the cell membrane PKC activity in FSC cultures in a dose-dependent way. Intracellular cAMP levels were not significantly modified by acetaldehyde in the first 30 min of incubation. We conclude that acetaldehyde increases procollagen I and fibronectin gene transcription in FSCs, possibly through c-fos and c-jun expression, and that PKC may play a regulatory role in this chain of events.


Subject(s)
Acetaldehyde/pharmacology , Protein Kinase C/metabolism , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins c-jun/genetics , Animals , Blotting, Northern , Cells, Cultured , Collagen/genetics , Cyclic AMP/metabolism , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Female , Fibronectins/genetics , Gene Expression Regulation/drug effects , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Transcription, Genetic/drug effects
15.
Biochem Biophys Res Commun ; 199(2): 1019-26, 1994 Mar 15.
Article in English | MEDLINE | ID: mdl-8135774

ABSTRACT

Undulin and fibronectin (FN) are large extracellular matrix (ECM) glycoproteins possibly involved in cell-matrix interactions. In this study we analyzed the effect of acetaldehyde and transforming growth factor-beta 1 (TGF-beta 1) on undulin and FN synthesis in cultured fat-storing cells (FSC) isolated from wedge sections of normal human livers. Cultured human FSC expressed two mRNA transcripts (6.5 and 8.5 kb) specific for undulin. Acetaldehyde inhibited both undulin mRNA and protein expression, whereas it had an opposite (stimulatory) effect on FN synthesis. TGF-beta 1 induced a dose-dependent increase of both undulin and FN synthesis in FSC cultures. Furthermore, TGF-beta 1 antagonized the inhibitory effect of acetaldehyde on undulin production and potentiated the stimulatory effect of acetaldehyde on FN synthesis. Since undulin is involved in the supramolecular organization of fibrillar collagens and in their enzymatic degradation, its acetaldehyde-induced inhibition may contribute to ECM rearrangement in the early stages of alcoholic liver fibrosis.


Subject(s)
Acetaldehyde/pharmacology , Collagen/biosynthesis , Fibronectins/biosynthesis , Gene Expression Regulation/drug effects , Glycoproteins/biosynthesis , Liver/metabolism , Transforming Growth Factor beta/pharmacology , Cells, Cultured , Collagen/genetics , Extracellular Matrix/drug effects , Extracellular Matrix/metabolism , Glycoproteins/genetics , Humans , Kinetics , Liver/cytology , Liver/drug effects , RNA, Messenger/biosynthesis , RNA, Messenger/metabolism , Transcription, Genetic/drug effects
16.
Life Sci ; 55(17): 1311-6, 1994.
Article in English | MEDLINE | ID: mdl-7934638

ABSTRACT

Altered degradation of extracellular matrix has been implicated in the pathogenesis of hepatic fibrosis. We studied the effect of acetaldehyde (AcCHO) on gene expression of matrix-metalloproteinase (MMP)-1 (fibroblast type- interstitial collagenase) and MMP-2 (72 kDa gelatinase-type IV collagenase) in comparison with the AcCHO effect on collagen type I and IV synthesis in cultures of fat-storing cells (FSC) isolated from normal human livers. Cultured human FSC expressed single mRNA transcripts (2.7 and 3.2 kb) specific for MMP-1 and MMP-2, respectively. AcCHO inhibited MMP-1 mRNA levels, whereas it stimulated collagen type I mRNA and protein expression. Opposite AcCHO effects were evident on MMP-2 mRNA and collagen IV synthesis, being MMP-2 up-regulated and collagen IV down-regulated. These data suggest that regulation of MMP-1 and MMP-2 genes by AcCHO may contribute to disruption of the normal basement membrane and its replacement with fibrillar collagens in the early stages of alcoholic liver fibrosis.


Subject(s)
Acetaldehyde/pharmacology , Collagenases/genetics , Extracellular Matrix/enzymology , Gene Expression Regulation, Enzymologic/drug effects , Liver/enzymology , Metalloendopeptidases/genetics , Cells, Cultured , Collagen/biosynthesis , Humans , Kinetics , Lipid Metabolism , Liver/cytology , Liver/metabolism , Matrix Metalloproteinase 1 , Matrix Metalloproteinase 9 , RNA, Messenger/metabolism
17.
Ann Thorac Surg ; 57(1): 65-70; discussion 71, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8279921

ABSTRACT

We tested in pigs the hypothesis that regional deep hypothermia of the spinal cord achieved by cerebrospinal fluid cooling will protect against ischemic injury during thoracic aortic cross-clamping. Eight control animals underwent aortic cross-clamping at the distal aortic arch and just above the diaphragm for 30 minutes. Eight experimental animals had placement of two subarachnoid perfusion catheters through laminectomies at T4 and the lower lumbar region. The subarachnoid space was perfused with normal saline solution at 6 degrees C delivered by gravity infusion, with infusion rates adjusted to maintain cord temperatures at less than 20 degrees C. After 30 minutes of aortic cross-clamping, the infusion was stopped and the cord allowed to warm to body temperature. Hind limb neurologic function was graded by Tarlov's scale. All of the animals in the control group had complete hind limb paraplegia (Tarlov grade 0) postoperatively. Seven of the 8 animals in the experimental group had preservation of hind limb motor function (Tarlov grade 2), and 1 animal had complete hind limb paraplegia (Tarlov grade 0) (p = 0.002, Fisher's exact test). We conclude that regional deep hypothermia of the spinal cord in pigs does provide some protection from ischemic injury during thoracic aortic cross-clamping. Clinically this may be a useful adjunct for prevention of paraplegia during thoracic aortic operations.


Subject(s)
Aorta, Thoracic , Hypothermia, Induced/methods , Ischemia/prevention & control , Paraplegia/prevention & control , Spinal Cord/blood supply , Animals , Body Temperature , Constriction , Spinal Cord/physiology , Swine
18.
J Hepatol ; 19(3): 385-92, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8151099

ABSTRACT

Hepatic fibrosis is an important morphological feature of alcohol-induced liver injury. We previously reported that acetaldehyde, but not ethanol can stimulate type I collagen and fibronectin synthesis in cultures of rat fat-storing cells (FSC) by increasing transcription of the specific genes. The effect of lactate and pyruvate was studied on collagen I, III, fibronectin accumulation by cultured rat FSCs and it was investigated whether acetaldehyde could increase procollagen I and fibronectin gene transcription through the formation of protein adducts. Lactate and pyruvate (5, 15 and 25 mmol/l) did not significantly affect collagen I, III and fibronectin production by cultured FSCs. Pyridoxal-phosphate and p-hydroxymecuribenzoate (inhibitors of acetaldehyde-protein adduct formation) blocked the stimulatory effect of acetaldehyde on procollagen I and fibronectin gene transcription. These data suggest that ethanol may act as a liver fibrogenic factor through acetaldehyde, its immediate metabolite, whereas lactate does not seem to play a role. Acetaldehyde might stimulate gene transcription of extracellular matrix components by liver FSCs through the formation of adducts with proteins.


Subject(s)
Adipocytes/drug effects , Collagen/biosynthesis , Fibronectins/biosynthesis , Liver/drug effects , Transcription, Genetic/drug effects , Acetaldehyde/chemistry , Adipocytes/metabolism , Animals , Female , Lactates/pharmacology , Lactic Acid , Liver/cytology , Liver/metabolism , Proteins/chemistry , Pyruvates/pharmacology , Pyruvic Acid , Rats , Rats, Sprague-Dawley
19.
Conn Med ; 55(4): 200-2, 1991 Apr.
Article in English | MEDLINE | ID: mdl-2070605

ABSTRACT

We describe a case of recurrent dedifferentiated retroperitoneal liposarcoma with light microscopy features of rhabdomyosarcoma, the first such reported case. The tumor contains a pleomorphic pattern consisting of plump fusiform cells, tadpole cells, malignant appearing lipoblasts, and other nondescript bizarre cells. Of particular interest is a number of tumor cells with plump, bizarre nuclei which contain cross-striations of skeletal muscle pattern. The literature on dedifferentiated liposarcoma is reviewed, and the significance of this case in terms of a current model of mesenchymal differentiation is discussed, with particular attention to the postulate of a common precursor for a variety of soft-tissue tumor histologies.


Subject(s)
Liposarcoma/pathology , Neoplasm Recurrence, Local/pathology , Retroperitoneal Neoplasms/pathology , Rhabdomyosarcoma/pathology , Cell Differentiation , Humans , Liposarcoma/ultrastructure , Male , Microscopy , Middle Aged , Retroperitoneal Neoplasms/ultrastructure , Rhabdomyosarcoma/ultrastructure
20.
Life Sci ; 49(21): PL163-8, 1991.
Article in English | MEDLINE | ID: mdl-1943455

ABSTRACT

We investigated whether calcitonin gene-related peptide (CGRP) was able to affect the production of collagen and glycosaminoglycans (GAG) in cultures of rat fat-storing cells (FSC). Rat CGRP (1 nM-1 microM) induced a dose-dependent increase of total GAG production in FSC cultures with an EC50 of 28 nM. One uM human CGRP (8-37) shifted the dose-response curve of rat CGRP to the right (EC50 = 257 nM) without depressing the maximal response. Salmon calcitonin (1 nM-1 microM) did not significantly modify total GAG accumulation in FSC cultures. Collagen type I and III production was not significantly affected by either CGRP or calcitonin in FSC cultures. These findings suggest that peripheral sensory neuropeptides may modulate liver fibrogenesis.


Subject(s)
Adipose Tissue/metabolism , Calcitonin Gene-Related Peptide/pharmacology , Collagen/biosynthesis , Glycosaminoglycans/biosynthesis , Liver/metabolism , Adipose Tissue/cytology , Animals , Calcitonin/pharmacology , Cells, Cultured , Female , Liver/cytology , Rats , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL